Bausch & Lomb (NYSE:BLCO) reported quarterly earnings results on February 18, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $0.32, missing the consensus estimate of $0.35 by $0.03 per share. Revenue came in at $1.4B, beating the estimate of $1.4B.
Bausch & Lomb's stock moved following the earnings release. The stock currently trades at $17.57 with a market capitalization of $6.1B.
